fluoxetine has been researched along with s 8932 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Brunotte, L; Ludwig, S; Mecate-Zambrano, A; Rescher, U; Schloer, S; Tang, J; Zheng, S | 1 |
1 other study(ies) available for fluoxetine and s 8932
Article | Year |
---|---|
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Fluoxetine; Hepatitis C, Chronic; Humans; Itraconazole; Pharmaceutical Preparations; SARS-CoV-2 | 2021 |